The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Xiamen Changrong Investment Management, Ming Bioventures, JMCR Partners.
The high activity for fund was in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year.
Among the most popular fund investment industries, there are Health Care, Medical. Among the various public portfolio startups of the fund, we may underline Viva Biotech Besides, a startup needs to be aged 11-15 years to get the investment from the fund.
| Fund Name | Location |
| Arantus | Stockholm, Stockholm County, Sweden |
| Athenian Venture Partners | Florida, Fort Lauderdale, United States |
| Cambridge Information Group | New York, New York, United States |
| CGN Nuclear Technology Development | Beijing, China, Haidian |
| E-hualu | Beijing, China, Shijingshan |
| Grupo Zriser | Spain, Valencia, Valencian Community |
| Innpulsa Colombia | Buenaventura, Colombia, Valle del Cauca |
| Keyhaven Capital Partners | England, London, United Kingdom |
| McCain Foods | Canada, Ontario, Toronto |
| Milar Ventures | - |
| Seabed VC | California, Saratoga, United States |
| The California Wellness Foundation | California, Los Angeles, United States |
| Ultramagic Balloons | - |
| Upslope Ventures | Colorado, Denver, United States |
| Viking Maccabee Ventures | - |
| Yingshan Investment Management | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
VivaVision Biotech | $10M | 26 Sep 2019 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
VivaVision Biotech | $10M | 26 Sep 2019 | Shanghai, China |
